| John V Vanore, DPM | |
|
306 S 4th St, Gadsden, AL 35901-5213 | |
| (256) 547-1631 | |
| Not Available |
| Full Name | John V Vanore |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Foot Surgery |
| Location | 306 S 4th St, Gadsden, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467518605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | 203 (Alabama) | Primary |
| Provider Name | Gadsden Foot Clinic, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710043856 PECOS PAC ID: 8921025024 Enrollment ID: O20051027001162 |
News Archive
Liver damage caused by medicinal drugs is one of the most common reasons for liver failure and liver transplants in the Western world. Nevertheless, it is difficult to predict which active ingredients will turn out to be toxic for the organ. Oftentimes the problems are not discovered until the drug is already on the market. Prof. Dr. Jens Timmer, Freiburg physicist and Director of the FRIAS School of Life Sciences - LifeNet, is a project partner in a consortium that wants to solve this problem.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from a pilot clinical study to assess safety, tolerability, and multiple-dose pharmacokinetics of XIAFLEX (collagenase clostridium histolyticum) in adult Dupuytren's contracture subjects with multiple palpable cords.
Senesco Technologies, Inc. reported today on the progress of its Phase 1b/2a study for the treatment of multiple myeloma, which is the subject of a poster presented today at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between the two strategies, according to data presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.
Inhibition of transcription factor E2F1 reduced epidermal growth factor receptor (EGFR) expression and reduced the invasive potential but not proliferation of metastatic melanoma cells, according to a brief communication published online December 23 in the Journal of the National Cancer Institute.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John V Vanore, DPM 306 S 4th St, Gadsden, AL 35901-5213 Ph: (256) 547-1631 | John V Vanore, DPM 306 S 4th St, Gadsden, AL 35901-5213 Ph: (256) 547-1631 |
News Archive
Liver damage caused by medicinal drugs is one of the most common reasons for liver failure and liver transplants in the Western world. Nevertheless, it is difficult to predict which active ingredients will turn out to be toxic for the organ. Oftentimes the problems are not discovered until the drug is already on the market. Prof. Dr. Jens Timmer, Freiburg physicist and Director of the FRIAS School of Life Sciences - LifeNet, is a project partner in a consortium that wants to solve this problem.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from a pilot clinical study to assess safety, tolerability, and multiple-dose pharmacokinetics of XIAFLEX (collagenase clostridium histolyticum) in adult Dupuytren's contracture subjects with multiple palpable cords.
Senesco Technologies, Inc. reported today on the progress of its Phase 1b/2a study for the treatment of multiple myeloma, which is the subject of a poster presented today at the 2012 Annual Meeting of the American Society of Clinical Oncology.
Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between the two strategies, according to data presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.
Inhibition of transcription factor E2F1 reduced epidermal growth factor receptor (EGFR) expression and reduced the invasive potential but not proliferation of metastatic melanoma cells, according to a brief communication published online December 23 in the Journal of the National Cancer Institute.
› Verified 2 days ago
Dr. Brooke Leann Gorham, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 306 S 4th St, Gadsden, AL 35901 Phone: 256-547-1631 Fax: 256-547-1632 | |
Dr. Michael D Chmielewski, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 230 S 4th St, Gadsden, AL 35901 Phone: 256-549-7890 Fax: 256-549-7891 | |
Dr. Henry Lane Bradford, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1020 Tuscaloosa Ave, Gadsden, AL 35901 Phone: 256-492-0131 | |
Dr. Shannon M Deaton, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 230 S 4th St, Gadsden, AL 35901 Phone: 256-549-7890 Fax: 256-549-7891 | |
Jean Pratt, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 306 S 4th St, Gadsden, AL 35901 Phone: 256-547-1631 Fax: 256-547-1632 | |
Gadsden Foot Clinic, P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 306 S 4th St, Gadsden, AL 35901 Phone: 256-547-1631 Fax: 256-547-1632 |